Therapeutic Asset Ratings
168 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Bcma/Gprc5D Car-T Cells
Sarcoma of Bone
Essen Biotech
P1/2
CCC
(48)
Bcma/Gprc5D Car-T Cells
Sarcomas, Germinoblastic
Essen Biotech
P1/2
CCC
(48)
Bcma/Gprc5D Car-T Cells
Sarcoma,Soft Tissue
Essen Biotech
P1/2
CCC
(48)
Bcma/Gprc5D Car-T Cells
Sarcoma, Synovial
Essen Biotech
P1/2
CCC
(48)
cd146/her2 car-t cells
Sarcoma, Ewing
Essen Biotech
P1/2
CCC
(48)
cd146/her2 car-t cells
Sarcoma, Kaposi
Essen Biotech
P1/2
CCC
(48)
cd146/her2 car-t cells
Sarcoma of Bone
Essen Biotech
P1/2
CCC
(48)
cd146/her2 car-t cells
Sarcomas, Germinoblastic
Essen Biotech
P1/2
CCC
(48)
cd146/her2 car-t cells
Sarcoma,Soft Tissue
Essen Biotech
P1/2
CCC
(48)
cd146/her2 car-t cells
Sarcoma, Synovial
Essen Biotech
P1/2
CCC
(48)
cd5/cd7 car-t
T Cell Childhood ALL
Essen Biotech
P1/2
CCC
(48)
cd5/cd7 car-t
T Cell Leukemia
Essen Biotech
P1/2
CCC
(48)
cd5/cd7 car-t
T-Cell Lymphoma of CNS
Essen Biotech
P1/2
CCC
(48)
cd5/cd7 car-t
T Cell Prolymphocytic Leukemia
Essen Biotech
P1/2
CCC
(48)
Claudin18.2 Car-T Cells
Advanced Pancreatic Carcinoma
Essen Biotech
P1/2
CCC
(48)
Cyclophosphamide
Ovarian Sarcoma
Essen Biotech
P1/2
CCC
(48)
Dual-Target Antigen-Selected Car-Nk
Prostate Cancer - Recurrent
Essen Biotech
P1/2
CCC
(48)
EBNK-001
Lung Cancer (Diagnosis)
Essen Biotech
P1/2
CCC
(48)
Eb-Select Single-Target Car-Nk Cells
Prostate Cancer - Recurrent
Essen Biotech
P1/2
CCC
(48)
Fludarabine
Ovarian Sarcoma
Essen Biotech
P1/2
CCC
(48)
Fludarabine
Sarcoma, Kaposi
Essen Biotech
P1/2
CCC
(48)
gpc3 cd146 car-t cells
Ovarian Sarcoma
Essen Biotech
P1/2
CCC
(48)
il-15
Lung Cancer (Diagnosis)
Essen Biotech
P1/2
CCC
(48)
TIL
Breast Cancer Triple Negative
Essen Biotech
P1/2
CCC
(48)
TIL
Gliomas, Malignant
Essen Biotech
P1/2
CCC
(48)
Showing 51 to 75 of 168 assets
Previous
Page 3 of 7
Next